Read More
GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma"
Post a Comment